NOVAVAX INC — Investor Relations & Filings
Filings indexed
1,095
across all filing types
Latest filing
2026-05-06
Regulatory Filings
Country
US
United States of America
Listing
US
NVAX
Novavax Inc. is a biotechnology company that develops and commercializes vaccines to prevent serious infectious diseases. The company utilizes a proprietary, protein-based vaccine technology platform, which includes its novel Matrix-M™ adjuvant, to create its vaccine candidates. Its primary commercial product is a protein-based COVID-19 vaccine, Nuvaxovid™. Novavax's research and development pipeline is focused on addressing significant health needs, including influenza and a combination COVID-19-influenza vaccine. The company's strategy emphasizes advancing its pipeline assets and establishing strategic partnerships to maximize the global health impact of its technology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - NOVAVAX INC (0001000694) (Filer) | 2026-05-06 | English | |
| 10-Q - NOVAVAX INC (0001000694) (Filer) | 2026-05-06 | English | |
| ARS - NOVAVAX INC (0001000694) (Filer) | 2026-04-27 | English | |
| 4 - NOVAVAX INC (0001000694) (Filer) | 2026-03-03 | English | |
| 4 - NOVAVAX INC (0001000694) (Filer) | 2026-03-03 | English | |
| 4 - NOVAVAX INC (0001000694) (Filer) | 2026-03-03 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 41825187 | 8-K - NOVAVAX INC (0001000694) (Filer) | 2026-05-06 | English | ||
| 41821544 | 10-Q - NOVAVAX INC (0001000694) (Filer) | 2026-05-06 | English | ||
| 37478022 | ARS - NOVAVAX INC (0001000694) (Filer) | 2026-04-27 | English | ||
| 32884992 | 4 - NOVAVAX INC (0001000694) (Filer) | 2026-03-03 | English | ||
| 32884993 | 4 - NOVAVAX INC (0001000694) (Filer) | 2026-03-03 | English | ||
| 32884994 | 4 - NOVAVAX INC (0001000694) (Filer) | 2026-03-03 | English | ||
| 32884995 | 4 - NOVAVAX INC (0001000694) (Filer) | 2026-03-03 | English | ||
| 32884996 | 8-K - NOVAVAX INC (0001000694) (Filer) | 2026-02-26 | English | ||
| 32885000 | 10-K - NOVAVAX INC (0001000694) (Filer) | 2026-02-26 | English | ||
| 26109679 | 4 Filing | 2026-01-26 | English | ||
| 26109797 | 8-K Filing | 2026-01-20 | English | ||
| 26109688 | 8-K Filing | 2026-01-12 | English | ||
|
2025
3 filings
| |||||
| 10610605 | OWNERSHIP DOCUMENT | 2025-12-15 | English | ||
| 10610606 | OWNERSHIP DOCUMENT | 2025-11-13 | English | ||
| 10610607 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
NOVAVAX INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31982/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31982 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31982 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31982 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31982}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for NOVAVAX INC (id: 31982)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.